ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Psychiatry Prescribers in Massachusetts

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JAY POMERANTZ M.D.

Psychiatry

472

$49.6K

37
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 20%

$105
Average prescription price

Avg: $110

KELLY WAHLEN MD

Psychiatry

467

$32K

32
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 20%

$68
Average prescription price

Avg: $110

STUART ANFANG M.D.

Psychiatry

467

$41.4K

79
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$89
Average prescription price

Avg: $110

BENNETT GURIAN M.D.

Psychiatry

460

$42K

43
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$91
Average prescription price

Avg: $110

THEODORE JELLINEK MD

Psychiatry

459

$29.5K

52
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 20%

$64
Average prescription price

Avg: $110

CHARLES SILBERSTEIN M.D.

Psychiatry

452

$42.8K

22
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 20%

$95
Average prescription price

Avg: $110

ELEANOR TEDESCO MD

Psychiatry

452

$24.1K

46
42 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

7%
prescriptions for brand name drugs

Avg: 20%

$53
Average prescription price

Avg: $110

JOHN PETEET MD

Psychiatry

448

$22.5K

54
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 20%

$50
Average prescription price

Avg: $110

MICHAEL BENNETT M.D.

Psychiatry

446

$49.7K

48
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$111
Average prescription price

Avg: $110

ANNE FENTON M.D.

Psychiatry

445

$26.1K

22
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 20%

$59
Average prescription price

Avg: $110

GARY GOLDSMITH M.D.

Psychiatry

442

$12.9K

34
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

16%
prescriptions for brand name drugs

Avg: 20%

$29
Average prescription price

Avg: $110

JEAN BOYD M.D.

Psychiatry

438

$53.8K

48
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 20%

$123
Average prescription price

Avg: $110

NATALIE LENDER M.D.

Psychiatry

434

$52.6K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 20%

$121
Average prescription price

Avg: $110

IRENE COLETSOS M.D.

Psychiatry

433

$23.7K

22
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

11%
prescriptions for brand name drugs

Avg: 20%

$55
Average prescription price

Avg: $110

ROBERT ABERNETHY MD

Psychiatry

433

$45.5K

33
11 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

13%
prescriptions for brand name drugs

Avg: 20%

$105
Average prescription price

Avg: $110

JESSE GOODMAN M.D.

Psychiatry

425

$42.7K

17
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 20%

$101
Average prescription price

Avg: $110

KIMBERLY RAWLINS M.D.

Psychiatry

422

$44.6K

28
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

14%
prescriptions for brand name drugs

Avg: 20%

$106
Average prescription price

Avg: $110

STEVEN GREENBERG MD PHD

Psychiatry

417

$48.2K

49
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 20%

$116
Average prescription price

Avg: $110

PAUL CANNISTRARO M.D.

Psychiatry

415

$49.8K

18
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 20%

$120
Average prescription price

Avg: $110

ELIZABETH SPARK M.D.

Psychiatry

413

$82.6K

18
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 20%

$200
Average prescription price

Avg: $110

JOHN WINKELMAN PHD/MD

Psychiatry

409

$119K

52
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 20%

$292
Average prescription price

Avg: $110

CARL FULWILER M.D.

Psychiatry

405

$61.9K

25
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

44%
prescriptions for brand name drugs

Avg: 20%

$153
Average prescription price

Avg: $110

PETER MUSLINER MD

Psychiatry

404

$27K

27
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

12%
prescriptions for brand name drugs

Avg: 20%

$67
Average prescription price

Avg: $110

FLOAREA PENTIUC MD

Psychiatry

398

$23.5K

34
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 20%

$59
Average prescription price

Avg: $110

CHRISTOPHER LUKONIS M.D.

Psychiatry

391

$46.6K

31
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

90%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

84%
prescriptions for brand name drugs

Avg: 20%

$119
Average prescription price

Avg: $110

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank